1. Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio. Issue 2 (11th November 2020) Authors: Crosby, Erika J; Hobeika, Amy C; Niedzwiecki, Donna; Rushing, Christel; Hsu, David; Berglund, Peter; Smith, Jonathan; Osada, Takuya; Gwin III, William R; Hartman, Zachary C; Morse, Michael A; Lyerly, Herbert Kim Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio. Issue 2 (11th November 2020) Authors: Crosby, Erika J; Hobeika, Amy C; Niedzwiecki, Donna; Rushing, Christel; Hsu, David; Berglund, Peter; Smith, Jonathan; Osada, Takuya; Gwin III, William R; Hartman, Zachary C; Morse, Michael A; Lyerly, Herbert Kim Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio. Issue 2 (11th November 2020) Authors: Crosby, Erika J; Hobeika, Amy C; Niedzwiecki, Donna; Rushing, Christel; Hsu, David; Berglund, Peter; Smith, Jonathan; Osada, Takuya; Gwin III, William R; Hartman, Zachary C; Morse, Michael A; Lyerly, Herbert Kim Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio. Issue 2 (11th November 2020) Authors: Crosby, Erika J; Hobeika, Amy C; Niedzwiecki, Donna; Rushing, Christel; Hsu, David; Berglund, Peter; Smith, Jonathan; Osada, Takuya; Gwin III, William R; Hartman, Zachary C; Morse, Michael A; Lyerly, Herbert Kim Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio. Issue 2 (11th November 2020) Authors: Crosby, Erika J; Hobeika, Amy C; Niedzwiecki, Donna; Rushing, Christel; Hsu, David; Berglund, Peter; Smith, Jonathan; Osada, Takuya; Gwin III, William R; Hartman, Zachary C; Morse, Michael A; Lyerly, Herbert Kim Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗